Insuman Infusat

Insulin Human, the active ingredient in Insuman Infusat, is an insulin presented as a sterile solution for subcutaneous use. It replaces deficient endogenous insulin and helps control blood glucose levels in individuals with type 1 or type 2 diabetes mellitus.

GNH USA supplies Insuman Infusat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide, adhering to stringent quality standards and providing reliable global distribution. The company offers comprehensive support for regulatory documentation and cold‑chain logistics where required. Clients benefit from dedicated technical assistance and timely delivery.

Insuman Infusat, a human insulin, acts on the insulin pathway to regulate glucose metabolism in diabetes.

- Type 1 Diabetes Mellitus: provides basal insulin to maintain glucose control. - Type 2 Diabetes Mellitus: used when oral agents are insufficient to achieve target glycaemia. - Diabetic Ketoacidosis: administered for rapid reduction of hyperglycemia. - Hospitalized Hyperglycemia: used to manage elevated blood glucose in acute care settings.

Insuman Infusat may be associated with several adverse reactions, ranging from frequent to rare.

Common Side Effects: - Hypoglycemia: low blood sugar episodes, especially if dosage exceeds needs. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: modest increase in body weight due to improved glucose utilization.

Serious or Rare Side Effects: - Severe hypoglycemia with loss of consciousness or seizures. - Allergic reactions: anaphylaxis, urticaria, or angioedema. - Lipodystrophy: abnormal fat accumulation or loss at injection sites.

Before initiating Insuman Infusat therapy, consider the following precautions to ensure safe and effective use. - Dose adjustment: modify dose in renal or hepatic impairment to avoid hypoglycemia. - Blood glucose monitoring: frequent checks are essential during dose changes or illness. - Hypoglycemia risk: do not administer if patient is already hypoglycemic. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Allergy: avoid if known hypersensitivity to human insulin or excipients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Infusat can interact with other medicines, influencing its glucose‑lowering effect or safety profile.

Major Interactions (Avoid): - Beta‑blockers: may mask hypoglycemia symptoms, requiring careful monitoring. - Alcohol: can potentiate insulin’s hypoglycemic action, increasing risk of low blood sugar. - MAO inhibitors: may enhance insulin’s effect, leading to severe hypoglycemia.

Moderate Interactions (Monitor Closely): - Sulfonylureas: additive glucose‑lowering effect, may cause hypoglycemia. - Thiazide diuretics: can increase blood glucose, potentially reducing insulin efficacy. - Corticosteroids: may raise glucose levels, necessitating dose adjustments.